AZD 6244

Kirsten rat sarcoma viral oncogene homolog ; Mus musculus







8 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34856074 Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatment. 2022 Mar 1
2 31804471 Heterogeneity and dynamics of active Kras-induced dysplastic lineages from mouse corpus stomach. 2019 Dec 5 1
3 29348467 Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model. 2018 Jan 18 1
4 29945997 Assessing Therapeutic Efficacy of MEK Inhibition in a KRASG12C-Driven Mouse Model of Lung Cancer. 2018 Oct 1 1
5 30021885 PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells. 2018 Jul 18 1
6 28938614 Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status. 2017 Aug 29 2
7 25541062 AZD6244 inhibits cisplatin-induced ERK1/2 activation and potentiates cisplatin-associated cytotoxicity in K-ras G12D preclinical models. 2015 Mar 1 2
8 22425996 A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response. 2012 Mar 18 3